Impact of polymorphisms in CYP and UGT enzymes and ABC and SLCO1B1 transporters on the pharmacokinetics and safety of desvenlafaxine

  1. Calleja, S.
  2. Zubiaur, P.
  3. Ochoa, D.
  4. Villapalos-García, G.
  5. Mejia-Abril, G.
  6. Soria-Chacartegui, P.
  7. Navares-Gómez, M.
  8. de Miguel, A.
  9. Román, M.
  10. Martín-Vílchez, S.
  11. Abad-Santos, F.
Aldizkaria:
Frontiers in Pharmacology

ISSN: 1663-9812

Argitalpen urtea: 2023

Alea: 14

Mota: Artikulua

DOI: 10.3389/FPHAR.2023.1110460 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak